Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT01788618
Eligibility Criteria:
Inclusion Criteria:
* Patients older than 18 years
* Solid tumor or haematological
* Chemotherapy and / or targeted therapy in the adjuvant or metastatic
* Sequential processing
* Subjective cognitive complaints during or after treatment assessed by four items of the FACT-COG (impact on quality of life). Score ≥ 4/16 questions Q35, Q37, Q38 and Q41 FACT COG - Patient in remission or pause therapeutic
* Subjective between 1 month and 5 years after the end of chemotherapy and / or targeted therapy cognitive complaints (ongoing treatment with Herceptin is not a non-inclusion criteria)
* Lack of personality disorders and / or psychiatric disorder scalable
* No known brain metastases
* Lack of primary brain tumor
* Lack of analgesic treatment with opioids or Class 3
* Having signed informed consent to participate in the study
* Mastery of the French language
Exclusion Criteria:
* Primary cancer of the central nervous system or brain metastases
* Pathology malignant hematologic
* Disorders of higher functions documented
* Pathology psychiatric scalable
* Use documented drug
* Cancer treated in childhood
* Patient or opioids analgesics in Class 3
* Consumption of alcohol
* Patient unable to respond to cognitive tests and cognitive rehabilitation
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01788618
Study Brief:
Protocol Section:
NCT01788618